Literature DB >> 25278689

Alcoholic liver disease: treatment.

Ki Tae Suk1, Moon Young Kim1, Soon Koo Baik1.   

Abstract

The excess consumption of alcohol is associated with alcoholic liver diseases (ALD). ALD is a major healthcare problem, personal and social burden, and significant reason for economic loss worldwide. The ALD spectrum includes alcoholic fatty liver, alcoholic hepatitis, cirrhosis, and the development of hepatocellular carcinoma. The diagnosis of ALD is based on a combination of clinical features, including a history of significant alcohol intake, evidence of liver disease, and laboratory findings. Abstinence is the most important treatment for ALD and the treatment plan varies according to the stage of the disease. Various treatments including abstinence, nutritional therapy, pharmacological therapy, psychotherapy, and surgery are currently available. For severe alcoholic hepatitis, corticosteroid or pentoxifylline are recommended based on the guidelines. In addition, new therapeutic targets are being under investigation.

Entities:  

Keywords:  Alcoholic; Liver disease; Treatment

Mesh:

Year:  2014        PMID: 25278689      PMCID: PMC4177474          DOI: 10.3748/wjg.v20.i36.12934

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  127 in total

1.  Intrahepatic gene expression in human alcoholic hepatitis.

Authors:  Devanshi Seth; Mark D Gorrell; Shaun Cordoba; Geoffrey W McCaughan; Paul S Haber
Journal:  J Hepatol       Date:  2006-06-05       Impact factor: 25.083

Review 2.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

3.  Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival.

Authors:  Timothy R Morgan; David G Weiss; Bernard Nemchausky; Eugene R Schiff; Bhupinder Anand; Francis Simon; Jayashri Kidao; Bennet Cecil; Charles L Mendenhall; Douglas Nelson; Charles Lieber; Marcos Pedrosa; Lennox Jeffers; John Bloor; Lawrence Lumeng; Luis Marsano; Craig McClain; Girish Mishra; Brent Myers; Maria Leo; Yelena Ponomarenko; Derek Taylor; Antonio Chedid; Samuel French; Gary Kanel; Natalie Murray; Paul Pinto; Tse-Ling Fong; Mike R Sather
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

4.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

5.  De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry.

Authors:  H W Park; S Hwang; C S Ahn; K H Kim; D B Moon; T Y Ha; G W Song; D H Jung; G C Park; J M Namgoong; S Y Yoon; C S Park; Y H Park; H J Lee; S G Lee
Journal:  Transplant Proc       Date:  2012-04       Impact factor: 1.066

6.  Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver.

Authors:  J Caballería; A Parés; C Brú; J Mercader; A García Plaza; L Caballería; G Clemente; L Rodrigo; J Rodés
Journal:  J Hepatol       Date:  1998-01       Impact factor: 25.083

7.  Are preoperative patterns of alcohol consumption predictive of relapse after liver transplantation for alcoholic liver disease?

Authors:  Pascal Perney; Michaël Bismuth; Hélène Sigaud; Marie Christine Picot; Eric Jacquet; Pierre Puche; Samir Jaber; Hélène Rigole; Françis Navarro; Jean-Jacques Eledjam; François Blanc; Dominique Larrey; Georges-Philippe Pageaux
Journal:  Transpl Int       Date:  2005-11       Impact factor: 3.782

8.  Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence.

Authors:  F Pessione; M J Ramond; L Peters; B N Pham; P Batel; B Rueff; D C Valla
Journal:  Liver Int       Date:  2003-02       Impact factor: 5.828

9.  Management of alcohol withdrawal delirium. An evidence-based practice guideline.

Authors:  Michael F Mayo-Smith; Lee H Beecher; Timothy L Fischer; David A Gorelick; Jeanette L Guillaume; Arnold Hill; Gail Jara; Chris Kasser; John Melbourne
Journal:  Arch Intern Med       Date:  2004-07-12

10.  Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis.

Authors:  S Hirsch; D Bunout; P de la Maza; H Iturriaga; M Petermann; G Icazar; V Gattas; G Ugarte
Journal:  JPEN J Parenter Enteral Nutr       Date:  1993 Mar-Apr       Impact factor: 4.016

View more
  10 in total

Review 1.  Microbiota-based treatments in alcoholic liver disease.

Authors:  Hotaik Sung; Seung Woo Kim; Meegun Hong; Ki Tae Suk
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 2.  Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.

Authors:  Min Seok Cho; Sang Yeol Kim; Ki Tae Suk; Byung-Yong Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

3.  Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.

Authors:  Meilan Xue; Ying Liu; Rui Lyu; Na Ge; Man Liu; Yan Ma; Hui Liang
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

4.  Protective effects of recombinant human cytoglobin against chronic alcohol-induced liver disease in vivo and in vitro.

Authors:  Jian Wen; Yongbin Wu; Wei Wei; Zhen Li; Ping Wang; Shiwei Zhu; Wenqi Dong
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

5.  Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.

Authors:  Torsten Diesinger; Vyacheslav Buko; Alfred Lautwein; Radovan Dvorsky; Elena Belonovskaya; Oksana Lukivskaya; Elena Naruta; Siarhei Kirko; Viktor Andreev; Dominik Buckert; Sebastian Bergler; Christian Renz; Edith Schneider; Florian Kuchenbauer; Mukesh Kumar; Cagatay Günes; Berthold Büchele; Thomas Simmet; Dieter Müller-Enoch; Thomas Wirth; Thomas Haehner
Journal:  PLoS One       Date:  2020-07-23       Impact factor: 3.240

6.  Nutritional Status and Diet Style Affect Cognitive Function in Alcoholic Liver Disease.

Authors:  Ye Rin Choi; Hyeong Seop Kim; Sang Jun Yoon; Na Young Lee; Haripriya Gupta; Ganesan Raja; Yoseph Asmelash Gebru; Gi Soo Youn; Dong Joon Kim; Young Lim Ham; Ki Tae Suk
Journal:  Nutrients       Date:  2021-01-09       Impact factor: 5.717

7.  Bioinformatics analysis of differentially expressed proteins in alcoholic fatty liver disease treated with recombinant human cytoglobin.

Authors:  Zi-Rong Zhang; Zheng-Gen Yang; Yan-Mei Xu; Zhe-Yan Wang; Jian Wen; Bo-Hong Chen; Ping Wang; Wei Wei; Zhen Li; Wen-Qi Dong
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

8.  Açaí (Euterpe oleracea Mart.) attenuates alcohol-induced liver injury in rats by alleviating oxidative stress and inflammatory response.

Authors:  Jianyu Zhou; Jianjun Zhang; Chun Wang; Shengsheng Qu; Yingli Zhu; Zhihui Yang; Linyuan Wang
Journal:  Exp Ther Med       Date:  2017-11-01       Impact factor: 2.447

9.  Protective Effects of Ethanolic Extracts from Artichoke, an Edible Herbal Medicine, against Acute Alcohol-Induced Liver Injury in Mice.

Authors:  Xuchong Tang; Ruofan Wei; Aihua Deng; Tingping Lei
Journal:  Nutrients       Date:  2017-09-11       Impact factor: 5.717

10.  The Role of Acetyl Cysteine in Cocaethylene (Non-Acetaminophen) Acute Liver Failure.

Authors:  Getaw Worku Hassen; Amaninder Dhaliwal; Catherine Ann Jenninigs; Hossein Kalantari
Journal:  Case Rep Emerg Med       Date:  2018-09-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.